AP-205™ is being developed as an ‘off-the-shelf’ CAR-engineered NK cell therapy which targets tumors expressing membrane Hsp70. Gene editing will improve persistence, potency and efficacy.
![](https://alphageneron.com/wp-content/uploads/2022/06/CAR-NK-cells.png)
AP-205™ is being developed as an ‘off-the-shelf’ CAR-engineered NK cell therapy which targets tumors expressing membrane Hsp70. Gene editing will improve persistence, potency and efficacy.